Literature DB >> 11274718

Nicotine-conditioned locomotor activity in rats: dopaminergic and GABAergic influences on conditioned expression.

R A Bevins1, J Besheer, K S Pickett.   

Abstract

Little is known about the processes that mediate acquisition and expression of conditioned associations between contextual cues and psychomotor effects of nicotine. In four separate experiments using rats, an environment repeatedly paired with nicotine acquired the ability to elicit increases in activity even in the absence of drug. This conditioned effect was sensitive to nicotine dose. Rats that had 0.6 or 1.2 mg/kg nicotine, but not 0.3 mg/kg, paired with the environment were more active than an unpaired control group (Experiment 1). In Experiment 2, control groups eliminated accounts based on nonspecific effects of nicotine and inhibitory conditioning decreasing activity in the unpaired controls of Experiment 1. Pretreatment on the test day with 100 mg/kg of gamma vinyl-GABA (GVG), a compound that inhibits the enzyme required to breakdown GABA, partially blocked the expression of locomotor conditioning without impairing activity in controls (Experiment 3). In Experiment 4, pretreatment on the test day with the dopamine D(1) receptor antagonist SCH-23390 (0.03 mg/kg) blocked expression of nicotine-conditioned locomotor activity; the D(2)/D(3) receptor antagonist eticlopride did not. Thus, the dopamine D(1) receptor subtype appears to play a role in context-elicited increases in activity conditioned by nicotine; GABA may also modulate the expression of this conditioned effect.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11274718     DOI: 10.1016/s0091-3057(00)00451-2

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  41 in total

1.  Diminished conditioned responding to the nicotine stimulus by antidepressant drugs with differing specificity for the serotonin and norepinephrine transporter.

Authors:  Amanda M Dion; Scott C Sanderson; L Charles Murrin; Rick A Bevins
Journal:  Pharmacol Biochem Behav       Date:  2011-10-08       Impact factor: 3.533

2.  The selective dopamine D3 receptor antagonist SB-277011A reduces nicotine-enhanced brain reward and nicotine-paired environmental cue functions.

Authors:  Arlene C Pak; Charles R Ashby; Christian A Heidbreder; Maria Pilla; Jeremy Gilbert; Zheng-Xiong Xi; Eliot L Gardner
Journal:  Int J Neuropsychopharmacol       Date:  2006-08-31       Impact factor: 5.176

3.  Acute stress and nicotine cues interact to unveil locomotor arousal and activity-dependent gene expression in the prefrontal cortex.

Authors:  Craig A Schiltz; Ann E Kelley; Charles F Landry
Journal:  Biol Psychiatry       Date:  2006-04-21       Impact factor: 13.382

4.  Acquisition and extinction of conditioned nicotine analgesic tolerance.

Authors:  Julian L Azorlosa; Carolyn E Johnson; James J McConnell
Journal:  Learn Behav       Date:  2006-08       Impact factor: 1.986

5.  Interoceptive conditioning in rats: effects of using a single training dose or a set of 5 different doses of nicotine.

Authors:  Steven T Pittenger; Rick A Bevins
Journal:  Pharmacol Biochem Behav       Date:  2013-11-05       Impact factor: 3.533

6.  Behavioral effects of phencyclidine on nicotine self-administration and reinstatement in the presence or absence of a visual stimulus in rats.

Authors:  Natashia Swalve; Steven T Pittenger; Rick A Bevins; Ming Li
Journal:  Psychopharmacology (Berl)       Date:  2015-04-07       Impact factor: 4.530

7.  Effects of the phencyclidine model of schizophrenia and nicotine on total and categorized ultrasonic vocalizations in rats.

Authors:  Natashia Swalve; Michele M Mulholland; Tiffany D Schulz; Ming Li
Journal:  Behav Pharmacol       Date:  2016-06       Impact factor: 2.293

8.  Vendor differences in alcohol consumption and the contribution of dopamine receptors to Pavlovian-conditioned alcohol-seeking in Long-Evans rats.

Authors:  Lindsay M Sparks; Joanna M Sciascia; Ziada Ayorech; Nadia Chaudhri
Journal:  Psychopharmacology (Berl)       Date:  2013-10-06       Impact factor: 4.530

9.  The interoceptive Pavlovian stimulus effects of caffeine.

Authors:  Jennifer E Murray; Chia Li; Matthew I Palmatier; Rick A Bevins
Journal:  Pharmacol Biochem Behav       Date:  2007-04-03       Impact factor: 3.533

10.  Mecamylamine, dihydro-beta-erythroidine, and dextromethorphan block conditioned responding evoked by the conditional stimulus effects of nicotine.

Authors:  Amanda M Struthers; Jamie L Wilkinson; Linda P Dwoskin; Peter A Crooks; Rick A Bevins
Journal:  Pharmacol Biochem Behav       Date:  2009-09-22       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.